These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2226793)

  • 1. Inhibition of thrombin by synthetic hirudin peptides.
    Binnie CG; Erickson BW; Hermans J
    FEBS Lett; 1990 Sep; 270(1-2):85-9. PubMed ID: 2226793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allosteric changes in thrombin's activity produced by peptides corresponding to segments of natural inhibitors and substrates.
    Hortin GL; Trimpe BL
    J Biol Chem; 1991 Apr; 266(11):6866-71. PubMed ID: 1849894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of in vitro clot growth by r-hirudin is more effective and longer sustained than by an analogous peptide.
    Römisch J; Stöhr HA; Stauss H; Koschinsky R; Stüber W; Pâques EP
    Thromb Haemost; 1994 Mar; 71(3):320-4. PubMed ID: 8029796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticoagulant activity of synthetic hirudin peptides.
    Maraganore JM; Chao B; Joseph ML; Jablonski J; Ramachandran KL
    J Biol Chem; 1989 May; 264(15):8692-8. PubMed ID: 2722794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of the inhibition of alpha-thrombin by hirudin-derived fragments hirudin(1-47) and hirudin(45-65).
    Schmitz T; Rothe M; Dodt J
    Eur J Biochem; 1991 Jan; 195(1):251-6. PubMed ID: 1991472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-function and refolding studies of the thrombin-specific inhibitor hirudin.
    Johnson PH; Sze P; Winant RC; Hudson D; Underhill P; Lazar JB; Olsen C; Almquist R
    Haemostasis; 1991; 21 Suppl 1():41-8. PubMed ID: 1894196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombin properties of C-terminus of hirudin using synthetic unsulfated N alpha-acetyl-hirudin45-65.
    Krstenansky JL; Mao SJ
    FEBS Lett; 1987 Jan; 211(1):10-6. PubMed ID: 3803584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithrombin activity of a peptide corresponding to residues 54-75 of heparin cofactor II.
    Hortin GL; Tollefsen DM; Benutto BM
    J Biol Chem; 1989 Aug; 264(24):13979-82. PubMed ID: 2760054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationships of recombinant hirudins.
    Stürzebecher J; Walsmann P
    Semin Thromb Hemost; 1991 Apr; 17(2):94-8. PubMed ID: 1771418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-function relationships of the C-terminal functional domain of hirudin and its variants.
    Krstenansky JL; Mao SJ
    Blood Coagul Fibrinolysis; 1991 Feb; 2(1):91-6. PubMed ID: 1773003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chimeric antithrombin peptide. Characterization of an Arg-Gly-Asp (RGD)- and hirudin carboxyl terminus-containing synthetic peptides.
    Church FC; Phillips JE; Woods JL
    J Biol Chem; 1991 Jun; 266(18):11975-9. PubMed ID: 2050691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production, properties, and thrombin inhibitory mechanism of hirudin amino-terminal core fragments.
    Chang JY
    J Biol Chem; 1990 Dec; 265(36):22159-66. PubMed ID: 2266119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the hirudin carboxy-terminal peptide 54-65 on the interaction of thrombin with platelets.
    Jandrot-Perrus M; Huisse MG; Krstenansky JL; Bezeaud A; Guillin MC
    Thromb Haemost; 1991 Sep; 66(3):300-5. PubMed ID: 1746000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombin-specific inhibition by and slow cleavage of hirulog-1.
    Witting JI; Bourdon P; Brezniak DV; Maraganore JM; Fenton JW
    Biochem J; 1992 May; 283 ( Pt 3)(Pt 3):737-43. PubMed ID: 1290488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-terminal requirements of small peptide anticoagulants based on hirudin54-65.
    Owen TJ; Krstenansky JL; Yates MT; Mao SJ
    J Med Chem; 1988 May; 31(5):1009-11. PubMed ID: 3361570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hirudin C-terminal fragments inhibit thrombin induced neutrophil chemotaxis.
    Rowand JK; Marucha P; Berliner LJ
    Thromb Haemost; 1992 Mar; 67(3):289-91. PubMed ID: 1641817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and characterization of more potent analogues of hirudin fragment 1-47 containing non-natural amino acids.
    De Filippis V; Quarzago D; Vindigni A; Di Cera E; Fontana A
    Biochemistry; 1998 Sep; 37(39):13507-15. PubMed ID: 9753436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hirudisins. Hirudin-derived thrombin inhibitors with disintegrin activity.
    Knapp A; Degenhardt T; Dodt J
    J Biol Chem; 1992 Dec; 267(34):24230-4. PubMed ID: 1447173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deciphering the structural elements of hirudin C-terminal peptide that bind to the fibrinogen recognition site of alpha-thrombin.
    Chang JY
    Biochemistry; 1991 Jul; 30(27):6656-61. PubMed ID: 2065053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombin inhibition by hirudin: how hirudin inhibits thrombin.
    Fenton JW; Villanueva GB; Ofosu FA; Maraganore JM
    Haemostasis; 1991; 21 Suppl 1():27-31. PubMed ID: 1894193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.